NCT02993133View on ClinicalTrials.gov

Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

April 30, 2019

Conditions
Autoimmune Bullous Dermatose
Interventions
DRUG

Cellcept® in autoimmune bullous dermatoses

The administration will follow the recommendations for the use of Cellcept® in autoimmune bullous dermatoses

Trial Locations (3)

Unknown

CHU de Bordeaux, Bordeaux

Hôpital Avicenne - AP-HP, Paris

CHU de Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT02993133 - Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid. | Biotech Hunter | Biotech Hunter